A PACT made in a London pub could lead to a cheap version of a drug that cures hepatitis C becoming available to millions of the world’s poorest people.
Around 200 million people worldwide suffer from the fatal liver disease (see Map), but only 30 million receive the expensive interferon-alpha that can cure them. “Our aim was to make a cheap, cost-effective version of the same drug so lots more people could benefit,” says Sunil Shaunak of Imperial College London, who set himself and colleague Steve Brocchini of the University of London’s School of Pharmacy the challenge while having…
